Benign Prostatic Hyperplasia Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.The Efficacy and Safety of Silodosin Singly or Combined With Ningmitai Capsules in the Treatment of Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms Interventions: Drug: Silodosin Capsules; Drug: Ningmitai capsule; Drug: Tamsulosin Sponsor: Xintian Pharmaceutical Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2022 Category: Research Source Type: clinical trials
Composite Steep-pulseTreatment Device Used in Patients With Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia Interventions: Device: Composite Steep-pulse Treatment Device; Drug: Tamsulosin Hydrochloride Capsules Sponsors: REMD Medical Technology; RenJi Hospital; Dongfang Hospital Affiliated to Tongji University; Shanghai Pudong Hospital; Qilu Hospital of Shandong University; Ningbo No.2 Hospital; Shangdong Yiyuan Hospital; Tongji Hospital; Sun Yat-Sen Memorial Hospital o f Sun Yat-Sen University; Hunan Provincial People's Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2022 Category: Research Source Type: clinical trials
